These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. First-trimester prediction of preeclampsia in nulliparous women at low risk. Myatt L; Clifton RG; Roberts JM; Spong CY; Hauth JC; Varner MW; Thorp JM; Mercer BM; Peaceman AM; Ramin SM; Carpenter MW; Iams JD; Sciscione A; Harper M; Tolosa JE; Saade G; Sorokin Y; Anderson GD; Obstet Gynecol; 2012 Jun; 119(6):1234-42. PubMed ID: 22617589 [TBL] [Abstract][Full Text] [Related]
4. Metalloprotease (ADAM12-S) as a predictor of preeclampsia: correlation with severity, maternal complications, fetal outcome, and Doppler parameters. El-Sherbiny W; Nasr A; Soliman A Hypertens Pregnancy; 2012; 31(4):442-50. PubMed ID: 22676623 [TBL] [Abstract][Full Text] [Related]
5. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction. Odibo AO; Zhong Y; Longtine M; Tuuli M; Odibo L; Cahill AG; Macones GA; Nelson DM Placenta; 2011 Apr; 32(4):333-8. PubMed ID: 21324404 [TBL] [Abstract][Full Text] [Related]
6. Efficiency of first-trimester uterine artery Doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein a, and maternal characteristics in the prediction of preeclampsia. Goetzinger KR; Zhong Y; Cahill AG; Odibo L; Macones GA; Odibo AO J Ultrasound Med; 2013 Sep; 32(9):1593-600. PubMed ID: 23980220 [TBL] [Abstract][Full Text] [Related]
7. First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction. Yu N; Cui H; Chen X; Chang Y Taiwan J Obstet Gynecol; 2017 Jun; 56(3):358-361. PubMed ID: 28600048 [TBL] [Abstract][Full Text] [Related]
8. The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia. Bestwick JP; George LM; Wu T; Morris JK; Wald NJ J Med Screen; 2012 Mar; 19(1):51-4. PubMed ID: 22357350 [TBL] [Abstract][Full Text] [Related]
9. Maternal characteristics, mean arterial pressure and serum markers in early prediction of preeclampsia. Kuc S; Koster MP; Franx A; Schielen PC; Visser GH PLoS One; 2013; 8(5):e63546. PubMed ID: 23717445 [TBL] [Abstract][Full Text] [Related]
10. Maternal serum disintegrin and metalloprotease protein-12 in early pregnancy as a potential marker of adverse pregnancy outcomes. Yang J; Wu J; Guo F; Wang D; Chen K; Li J; Du L; Yin A PLoS One; 2014; 9(5):e97284. PubMed ID: 24830297 [TBL] [Abstract][Full Text] [Related]
11. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Laigaard J; Sørensen T; Placing S; Holck P; Fröhlich C; Wøjdemann KR; Sundberg K; Shalmi AC; Tabor A; Nørgaard-Pedersen B; Ottesen B; Christiansen M; Wewer UM Obstet Gynecol; 2005 Jul; 106(1):144-9. PubMed ID: 15994630 [TBL] [Abstract][Full Text] [Related]
12. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia. Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883 [TBL] [Abstract][Full Text] [Related]
13. Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks. Poon LC; Chelemen T; Minekawa R; Frisova V; Nicolaides KH Am J Obstet Gynecol; 2009 May; 200(5):508.e1-6. PubMed ID: 19285649 [TBL] [Abstract][Full Text] [Related]
14. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. Wortelboer EJ; Koster MP; Cuckle HS; Stoutenbeek PH; Schielen PC; Visser GH BJOG; 2010 Oct; 117(11):1384-9. PubMed ID: 20840693 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of biochemical marker ADAM-12 at first trimester of pregnancy for hypertension and intrauterine growth restriction. Kasimis C; Evangelinakis N; Rotas M; Georgitsi M; Pelekanos N; Kassanos D Clin Exp Obstet Gynecol; 2016; 43(1):43-7. PubMed ID: 27048016 [TBL] [Abstract][Full Text] [Related]
16. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Audibert F; Boucoiran I; An N; Aleksandrov N; Delvin E; Bujold E; Rey E Am J Obstet Gynecol; 2010 Oct; 203(4):383.e1-8. PubMed ID: 20691410 [TBL] [Abstract][Full Text] [Related]
17. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Cowans NJ; Spencer K Prenat Diagn; 2007 Mar; 27(3):264-71. PubMed ID: 17278174 [TBL] [Abstract][Full Text] [Related]
18. ADAM12s in maternal serum as a potential marker of pre-eclampsia. Spencer K; Cowans NJ; Stamatopoulou A Prenat Diagn; 2008 Mar; 28(3):212-6. PubMed ID: 18264967 [TBL] [Abstract][Full Text] [Related]
20. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy. Spencer K; Cowans NJ J Matern Fetal Neonatal Med; 2007 Sep; 20(9):645-50. PubMed ID: 17701664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]